Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing
- 7 September 2021
- journal article
- research article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 29 (2) , 329-340
Abstract
Background Developing an alternative and efficient therapy for wound healing has been an important research topic for pharmaceutical sciences. A straightforward but effective system for delivering fibroblast growth factor-2 (FGF-2) encoding plasmid DNA (pFGF-2) for wound healing therapy was aimed to develop in this study. Methods In order to provide the delivery of pFGF-2, a delivery vector, namely, cationic lipid nanoparticle (cLN) was developed by the melt-emulsification process, complexed with pFGF-2 to form a lipoplex system and further characterized. The pFGF-2 binding and protecting ability of lipoplexes were evaluated. The cytotoxicity and transfection efficiency of the lipoplexes, FGF-2 expression levels, and in vitro wound healing ability have been investigated on the L929 fibroblast cell line. Results The obtained lipoplex system has a particle size of 88.53 nm with a low PDI (0.185), and zeta potential values of 27.8 mV with a spherical shape. The ability of cLNs to bind pFGF-2 and protect against nucleases was demonstrated by gel retardation assay. Furthermore, the developed FGF-2 carrying lipoplexes system showed significant transfection and FGF-2 expression ability comparing naked plasmid. Finally, scratch assay revealed that the developed system is able to promote in vitro cell proliferation/migration in 48 h. Conclusion Promising results have been achieved with the use of lipoplexes carrying pFGF-2, and this approach could be considered as a potentially applicable concept for the future gene-based wound healing therapies. Graphical abstractKeywords
Funding Information
- Izmir Katip Celebi University, Scientific Research Projects Coordinatorship
This publication has 44 references indexed in Scilit:
- Non-viral gene therapy: Gains and challenges of non-invasive administration methodsJournal of Controlled Release, 2016
- Non-invasive topical delivery of plasmid DNA to the skin using a peptide carrierJournal of Controlled Release, 2016
- Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysisEuropean Journal of Pharmaceutical Sciences, 2015
- Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanismsJournal of Controlled Release, 2015
- EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitroInternational Journal of Pharmaceutics, 2013
- Effects of Conformational Alteration Induced by d-/l-Isonucleoside Incorporation in siRNA on Their Stability in Serum and Silencing ActivityBioconjugate Chemistry, 2013
- Evaluation of the In Vitro Cytotoxicity of Cross-Linked BiomaterialsBiomacromolecules, 2013
- A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectorsJournal of Controlled Release, 2009
- Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmidEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Fibroblast Growth Factor-2 Induces Translational Regulation of Bcl-XL and Bcl-2 via a MEK-dependent PathwayJournal of Biological Chemistry, 2002